← Alle Unternehmen
Über das Unternehmen
As AI is transforming the way we design drugs, 5 years from now it will be easier than ever to design and make a drug. The real question will be: drug against what? This will put ever more focus on translational questions, such as identifying the right therapeutic target, the right patient population, the right biomarkers, etc. and moving fast in every such decision. At Navis Bio we are building a comprehensive knowledge base, analytics tools, and AI methods for translational research.